Effects of age on sugammadex reversal of neuromuscular blockade induced by rocuronium in Chinese children: a prospective pilot trial

[1] Meretoja OA(2010)Neuromuscular block and current treatment strategies for its reversal in children Paediatr Anaesth 20 591-604

[2] Murphy GS(2010)Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block Anesth Analg 111 120-128

[3] Brull SJ(2017)A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children Acta Anaesthesiol Scand 61 374-380

[4] Ammar AS(2003)Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action Anesthesiology. 98 1042-1048

[5] Mahmoud KM(2015)Postoperative residual neuromuscular paralysis at an Australian tertiary children’s hospital Anesthesiol Res Pract 2015 410248-877

[6] Kasemy ZA(2008)Concurrent use of anticholinergic drugs and cholinesterase inhibitors: register-based study of over 700,000 elderly patients Drugs Aging 25 871-1816

[7] Debaene B(2017)Preparing for the unexpected: special considerations and complications after sugammadex administration BMC Anesthesiol 17 140-1640

[8] Plaud B(2002)Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships J Med Chem 45 1806-125

[9] Dilly MP(2019)Reversibility of Rocuronium-induced deep neuromuscular block with Sugammadex in infants and children-a randomized study Biol Pharm Bull 42 1637-14

[10] Donati F(2017)Current evidence for the use of sugammadex in children Paediatr Anaesth 27 118-808

[1] Meretoja OA(2010)Neuromuscular block and current treatment strategies for its reversal in children Paediatr Anaesth 20 591-604

[2] Murphy GS(2010)Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block Anesth Analg 111 120-128

[3] Brull SJ(2017)A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children Acta Anaesthesiol Scand 61 374-380

[4] Ammar AS(2003)Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action Anesthesiology. 98 1042-1048

[5] Mahmoud KM(2015)Postoperative residual neuromuscular paralysis at an Australian tertiary children’s hospital Anesthesiol Res Pract 2015 410248-877

[6] Kasemy ZA(2008)Concurrent use of anticholinergic drugs and cholinesterase inhibitors: register-based study of over 700,000 elderly patients Drugs Aging 25 871-1816

[7] Debaene B(2017)Preparing for the unexpected: special considerations and complications after sugammadex administration BMC Anesthesiol 17 140-1640

[8] Plaud B(2002)Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships J Med Chem 45 1806-125

[9] Dilly MP(2019)Reversibility of Rocuronium-induced deep neuromuscular block with Sugammadex in infants and children-a randomized study Biol Pharm Bull 42 1637-14

[10] Donati F(2017)Current evidence for the use of sugammadex in children Paediatr Anaesth 27 118-808